Wednesday, July 1, 2015

Bone Marrow Transplantation - Table of Contents alert Volume 50 Issue 7

If you are unable to see the message below, click here to view.
Bone Marrow Transplantation

TABLE OF CONTENTS

Volume 50, Issue 7 (July 2015)

In this issue
Editorials
Reviews
Commentaries
Original Articles
Letters to the Editor
Corrigenda

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Editorials

Top

ABO, alemtuzumab and allogeneic transplantation

L Cooling

Bone Marrow Transplant 2015 50: 881-883; advance online publication, April 20, 2015; 10.1038/bmt.2015.77

Full Text

Engineering haploidentical transplants

S Naik and H E Heslop

Bone Marrow Transplant 2015 50: 884-885; advance online publication, May 11, 2015; 10.1038/bmt.2015.115

Full Text

Reviews

Top

Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective

F Saraceni, N Shem-Tov, A Olivieri and A Nagler

Bone Marrow Transplant 2015 50: 886-891; advance online publication, February 9, 2015; 10.1038/bmt.2014.330

Abstract | Full Text

G-CSF-primed BM for allogeneic SCT: revisited

I Pessach, I Resnick, A Shimoni and A Nagler

Bone Marrow Transplant 2015 50: 892-898; advance online publication, March 2, 2015; 10.1038/bmt.2015.25

Abstract | Full Text

Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection?

A E Harris, J Styczynski, M Bodge, M Mohty, B N Savani and P Ljungman

Bone Marrow Transplant 2015 50: 899-903; advance online publication, March 23, 2015; 10.1038/bmt.2015.49

Abstract | Full Text

Commentaries

Top

Sickle cell disease is not so benign

M M Hsieh

Bone Marrow Transplant 2015 50: 904; advance online publication, April 20, 2015; 10.1038/bmt.2015.65

Full Text

Leukemia cell mobilization: a road to eradication?

E A Copelan

Bone Marrow Transplant 2015 50: 905-906; advance online publication, April 20, 2015; 10.1038/bmt.2015.78

Full Text

Original Articles

Top

ACUTE LEUKEMIA

Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission

F V Michelis, E G Atenafu, V Gupta, D D Kim, J Kuruvilla, J H Lipton, D Loach, M D Seftel, J Uhm, N Alam, A Lambie, L McGillis and H A Messner

Bone Marrow Transplant 2015 50: 907-913; advance online publication, March 30, 2015; 10.1038/bmt.2015.59

Abstract | Full Text

PLASMA CELL DISORDERS

Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation

R F Cornell, X Zhong, C Arce-Lara, E Atallah, L Blust, W R Drobyski, T S Fenske, M C Pasquini, J D Rizzo, W Saber and P N Hari

Bone Marrow Transplant 2015 50: 914-917; advance online publication, April 27, 2015; 10.1038/bmt.2015.73

Abstract | Full Text

INHERITED AND GENETIC DISORDERS

Traffic Light: prognosis-based eligibility for clinical trials of hematopoietic SCT in adults with sickle cell anemia

S J Rotz, M A O'Riordan, C Kim, M de Lima, M T Gladwin and J A Little

Bone Marrow Transplant 2015 50: 918-923; advance online publication, March 16, 2015; 10.1038/bmt.2015.11

Abstract | Full Text

HEMATOPOIETIC CELL COLLECTION

Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers

N Anandasabapathy, G Breton, A Hurley, M Caskey, C Trumpfheller, P Sarma, J Pring, M Pack, N Buckley, I Matei, D Lyden, J Green, T Hawthorne, H C Marsh, M Yellin, T Davis, T Keler and S J Schlesinger

Bone Marrow Transplant 2015 50: 924-930; advance online publication, April 27, 2015; 10.1038/bmt.2015.74

Abstract | Full Text

CONDITIONING

Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT

C K Brierley, T J Littlewood, A J Peniket, R Gregg, J Ward, A Clark, A Parker, R Malladi and P Medd

Bone Marrow Transplant 2015 50: 931-938; advance online publication, April 13, 2015; 10.1038/bmt.2015.51

Abstract | Full Text

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan–fludarabine conditioning for allogeneic stem cell transplantation

M Konopleva, C B Benton, P F Thall, Z Zeng, E Shpall, S Ciurea, P Kebriaei, A Alousi, U Popat, P Anderlini, Y Nieto, S Parmar, W Qiao, J Chen, G Rondon, B McMullin, R-Y Wang, H Lu, W Schober, G Woodworth, A Gulbis, R Cool, M Andreeff and R Champlin

Bone Marrow Transplant 2015 50: 939-946; advance online publication, April 13, 2015; 10.1038/bmt.2015.58

Abstract | Full Text

SUPPORTIVE CARE

Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma

T M Graff, A K Singavi, W Schmidt, D Eastwood, W R Drobyski, M Horowitz, J Palmer, M Pasquini, D J Rizzo, W Saber, P Hari and T S Fenske

Bone Marrow Transplant 2015 50: 947-953; advance online publication, April 13, 2015; 10.1038/bmt.2015.46

Abstract | Full Text

TRANSPLANT TOXICITIES

Cardiac QTc interval characteristics before and after hematopoietic stem cell transplantation: an analysis of 995 consecutive patients at a single center

W P Miller, R Shanley and P Dorostkar

Bone Marrow Transplant 2015 50: 954-960; advance online publication, March 30, 2015; 10.1038/bmt.2015.64

Abstract | Full Text

GRAFT-VERSUS-HOST DISEASE

Meibography and meibomian gland measurements in ocular graft-versus-host disease

L A Engel, S Wittig, F Bock, L Sauerbier, C Scheid, U Holtick, J-M Chemnitz, M Hallek, C Cursiefen and P Steven

Bone Marrow Transplant 2015 50: 961-967; advance online publication, April 20, 2015; 10.1038/bmt.2015.72

Abstract | Full Text

IMMUNE RECOVERY

Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies

B M Triplett, D R Shook, P Eldridge, Y Li, G Kang, M Dallas, C Hartford, A Srinivasan, W K Chan, D Suwannasaen, H Inaba, T E Merchant, C-H Pui and W Leung

Bone Marrow Transplant 2015 50: 968-977; advance online publication, February 9, 2015; 10.1038/bmt.2014.324

Abstract | Full Text

Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial

C Cordonnier, M Labopin, C Robin, P Ribaud, L Cabanne, C Chadelat, S Cesaro and P Ljungman

Bone Marrow Transplant 2015 50: 978-983; advance online publication, April 13, 2015; 10.1038/bmt.2015.42

Abstract | Full Text

INFECTIONS

JC polyomavirus reactivation is common following allogeneic stem cell transplantation and its preemptive detection may prevent lethal complications

T Wittmann, N Horowitz, N Benyamini, I Henig, T Zuckerman, J M Rowe, Z Kra-Oz, M Szwarcwort Cohen, I Oren and I Avivi

Bone Marrow Transplant 2015 50: 984-991; advance online publication, April 13, 2015; 10.1038/bmt.2015.68

Abstract | Full Text

Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT

E Biagi, D Zama, C Nastasi, C Consolandi, J Fiori, S Rampelli, S Turroni, M Centanni, M Severgnini, C Peano, G de Bellis, G Basaglia, R Gotti, R Masetti, A Pession, P Brigidi and M Candela

Bone Marrow Transplant 2015 50: 992-998; advance online publication, April 20, 2015; 10.1038/bmt.2015.16

Abstract | Full Text

Letters to the Editor

Top

Outcomes for HIV-positive patients with primary central nervous system lymphoma after high-dose chemotherapy and auto-SCT

A O'Neill, K Mikesch, K Fritsch, B Kasenda, L Banerjee, F Burns, G Zakout, R Johnston, G Illerhaus and K Cwynarski

Bone Marrow Transplant 2015 50: 999-1000; advance online publication, April 13, 2015; 10.1038/bmt.2015.18

Full Text

Second haploidentical peripheral blood stem cell transplantation for treatment of acute leukemia with relapse after first allogeneic peripheral blood stem cell transplantation

S-P Yeh, C-C Lin, C-H Lin, W-C Lo, T-T Chen, W-J Lo, C-L Lin and C-F Chiu

Bone Marrow Transplant 2015 50: 1001-1003; advance online publication, April 13, 2015; 10.1038/bmt.2015.67

Full Text

Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profile

M-E M Percival, B C Medeiros, L Tian, S Robeson, G G Laport, L J Johnston, J A Shizuru, D B Miklos, S Arai, W-K Weng, R S Negrin and R Lowsky

Bone Marrow Transplant 2015 50: 1004-1006; advance online publication, April 20, 2015; 10.1038/bmt.2015.62

Full Text

Bone marrow aspiration technique has deteriorated in recent years

M Remberger, O Ringdén and J Mattsson

Bone Marrow Transplant 2015 50: 1007-1009; advance online publication, April 20, 2015; 10.1038/bmt.2015.75

Full Text

Fecal microbiota transplant for recurrent Clostridium difficile infection after peripheral autologous stem cell transplant for diffuse large B-cell lymphoma

C Mittal, N Miller, A Meighani, B R Hart, A John and M Ramesh

Bone Marrow Transplant 2015 50: 1010; advance online publication, April 20, 2015; 10.1038/bmt.2015.85

Full Text

Corrigenda

Top

ABO, alemtuzumab and allogeneic transplantation

L Cooling

Bone Marrow Transplant 2015 50: 1011; 10.1038/bmt.2015.140

Full Text

Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies

B M Triplett, D R Shook, P Eldridge, Y Li, G Kang, M Dallas, C Hartford, A Srinivasan, W K Chan, D Suwannasaen, H Inaba, T E Merchant, C-H Pui and W Leung

Bone Marrow Transplant 2015 50: 1012; 10.1038/bmt.2015.139

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: